Cargando…
Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011
OBJECTIVE: Evaluate the impact of radiotherapy on cause specific survival (CSS) and overall survival (OS) for stage (I–III) clear cell, mucinous, and endometriod ovarian cancer. METHODS: We analyzed incidence, survival, and treatments from the Surveillance, Epidemiology, and End Results (SEER) Progr...
Autores principales: | Patel, Sagar C., Frandsen, Jonathan, Bhatia, Sudershan, Gaffney, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944012/ https://www.ncbi.nlm.nih.gov/pubmed/27329193 http://dx.doi.org/10.3802/jgo.2016.27.e45 |
Ejemplares similares
-
Ovarian Metastasis in Endometriod Type Endometrial Cancer
por: Gilani Modaress, Mitra, et al.
Publicado: (2011) -
Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer
por: Ren, Caixia, et al.
Publicado: (2020) -
Common DNA methylation dynamics in endometriod adenocarcinoma and glioblastoma suggest universal epigenomic alterations in tumorigenesis
por: Karlow, Jennifer A., et al.
Publicado: (2021) -
Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer
por: Suhaimi, Siti Syazani, et al.
Publicado: (2018) -
Epidemiology and survival outcomes of mucinous adenocarcinomas: A SEER population-based study
por: Xie, Guang-Dong, et al.
Publicado: (2018)